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Prevalence of hip dislocation among children
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Abstract
Background: Hip dislocation is a serious complication among children with cerebral palsy (CP). The aim of this
study was to compare the prevalence of hip dislocation among children with CP in an area providing regular care
with an area providing hip surveillance services.
Methods: This is a cross-sectional study in seven Norwegian counties providing regular care and one Swedish
healthcare region where a hip surveillance programme was introduced in 1994. Data were provided by the
Norwegian Cerebral Palsy Register and the CP Register in Southern Sweden. Children born 1996 - 2003 with
moderate to severe CP, defined as Gross Motor Classification System (GMFCS) levels III - V, were included. In all, 119
Norwegian and 136 Swedish children fulfilled the criteria. In Norway, data on hip operations and radiographs of
the hips were collected from medical records, while these data are collected routinely in the Swedish register. The
hip migration percentage was measured on the recent radiographs. Hip dislocation was defined as a migration
percent of 100%.
Results: The proportion of children at GMFCS levels III - V was 34% in the Norwegian and 38% in the Swedish
population. In the Norwegian population, hip dislocation was diagnosed in 18 children (15.1%; CI: 9.8 - 22.6)
compared with only one child (0.7%; 95% CI: 0.01 - 4.0) in Southern Sweden (p = < 0.001). Hip surgery was
performed in 53 (44.5%) of the Norwegian children and in 43 (32%) of the Swedish children (p = 0.03). The total
number of hip operations was 65 in Norway and 63 in Sweden. Norwegian children were first operated at a mean
age of 7.6 years (SD: 2.9) compared with 5.7 years (SD: 2.3) in Sweden (p = 0.001).
Conclusions: The surveillance programme reduced the number of hip dislocations and the proportion of children
undergoing hip surgery was lower. However, with the surveillance programme the first operation was performed
at a younger age. Our results strongly support the effectiveness of a specifically designed follow-up programme for
the prevention of hip dislocation in children with CP.
Background
Dislocation of the hip among children with cerebral
palsy (CP) is a severe complication following insidious
hip displacement. Chronic increase in muscle tone, mus-
cle power imbalance and fixed contractures around the
hip joint together with unbalanced posture contribute to
the progressive displacement of the femoral head out of
the acetabular socket [1-4]. The prevalence of total hip
dislocation is reported to be 10 - 15% [5-7], while hip
displacement to various degrees is estimated to occur in
25 - 60% [3,8,9]. The risk of dislocation is increasing
with increased gross motor disability with the highest
risk among children at level five classified by the Gross
Motor Function Classification System (GMFCS)[10,11].
Hip dislocation is preventable, but detection of a hip
at risk must be based on both clinical and radiological
* Correspondence: areej.elkamil@ntnu.no
1Department of Laboratory Medicine, Children’s and Women’s Health,
Faculty of Medicine, Norwegian University of Science and Technology,
Trondheim, Norway
Full list of author information is available at the end of the article
Elkamil et al. BMC Musculoskeletal Disorders 2011, 12:284
http://www.biomedcentral.com/1471-2474/12/284
© 2011 Elkamil et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
examinations [7,9,12]. In Southern Sweden, a follow-up
programme for CP was started in 1994 with a specific
aim to identify patients at risk for hip dislocation and to
prevent this complication. During the following ten
years hip dislocation dropped from 8% to 0.5% [6].
Comparable results were reported from an Australian
programme introduced in 1997 [13]. However, during
the years when these follow-up programmes were imple-
mented, treatment of spasticity has dramatically
improved in particular through the introduction of
botulinum neurotoxin (BoNT) and intrathecal baclofen
[14,15]. Together with increased awareness of the risk of
hip displacement, these new treatment modalities might
have resulted in reduction of hip displacement even in
centres where the surveillance programme had not been
implemented.
Ideally the efficacy of a new treatment option should
be documented by randomised controlled trials (RCT).
However, in CP, comprising a heterogeneous group of
patients, conducting RCTs is difficult. A different
approach may, therefore, be to compare the outcome of
treatment in different treatment centres with otherwise
comparable quality of care, so called practice-based evi-
dence. Adopted in some fields of medicine, it is proved
to be useful in real life mainly due to the possibility of
comparing heterogeneous groups and including even
severely affected patients in contrast to RCTs with
restricted inclusion criteria [16]. An example of a similar
approach was used in the improvement in treatment of
children with acute lymphocytic leukaemia in the early
1980s [17].
The medical services and the level of care for children
with CP in the Scandinavian countries are quite similar
[18]. The aim of this study was, therefore, to compare
the prevalence of hip dislocation in a Norwegian popu-
lation receiving regular care with a group of children in
Southern Sweden included in the hip surveillance pro-
gramme, and to compare the number and type of hip
operations performed in these areas. Our main hypoth-
esis was that the prevalence of dislocation would be
higher in the areas providing regular care compared
with the area providing the surveillance services. Since
radiological screening from early childhood is an essen-
tial feature of the surveillance, resulting in the early
detection of candidates for preventive surgery, we also
hypothesised that the proportion of children operated,
and the number of hip operations, would be higher in
the surveillance area.
Materials and methods
This is a cross-sectional study in seven Norwegian
counties (total population: 2.0 million) and one Swedish
healthcare region (total population 1.4 million). The
population in the studied Norwegian counties
corresponds to 41% of the total population in Norway,
while in Sweden the studied background population
comprises 15% of the total population. Eligible for this
study were children born 1996 - 2003 with moderate to
severe CP estimated as GMFCS levels III - V.
In the Norwegian counties, all children with moderate
to severe CP visit a paediatric rehabilitation centre, at
least once a year. At these visits one main focus is on
motor function, spasticity treatment and the potential
need for surgery. However, for children born during
2003 and earlier there were no common guidelines to
identify children at risk for hip dislocations or for early
preventive surgery. Thus, the seven Norwegian counties
are in this study entitled the ‘regular care areas’. In
Southern Sweden, a follow up programme to prevent
hip dislocation was started in 1994 and this area is
entitled the ‘surveillance area’. The programme includes
annual radiological examination of children at GMFCS
levels III - V as soon as the diagnosis has been con-
firmed until the age of eight years. Above the age of
eight, the frequency of x-rays is individually evaluated
based on the results of earlier examinations. Children at
risk for hip dislocation are treated with early preventive
surgery. A similar surveillance programme has been suc-
cessively introduced in Norway since 2006, covering
whole Norway since 2010.
In Norway, data on hip displacement, orthopaedic sur-
gery, x-ray examinations and detailed spasticity treat-
ment were collected retrospectively for this study from
medical records in 2010, while other clinical data were
obtained from the Norwegian Cerebral Palsy Register. In
Southern Sweden all data were collected prospectively
(details of the two registers have been published)
[10,19,20].
According to the Surveillance of CP in Europe (SCPE)
definition, cerebral palsy is a “group of permanent and
non-progressive disorders of movement and posture
caused by a central nervous lesion, damage or dysfunc-
tion originating early in life” [21]. This definition, as
well as the classification of CP subtypes recommended
by SCPE, was used by the Norwegian and Swedish CP
registers.
Gross motor function of each child was estimated by
the treating rehabilitation centre and classified in the CP
registers into five levels according to the GMFCS, where
level I has the least and level V has the most severe
motor impairment [19,22,23].
In the Norwegian counties there were 494 children
with CP born between 1st January 1996 and 31st Decem-
ber 2003, corresponding to a prevalence of 2.65 per
1000 live births. Detailed clinical data were available on
357 of these children. The primary reason for the miss-
ing detailed data was work overload for local doctors.
Only one family refused to participate in the CP-
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register. We included all children who lived in the area
during the period 1996 to 2010 and those who died
before 1st January 2011 (n = 12). Of the 357 children
with detailed clinical data, 121 (33.9%) were classified as
GMFCS level III -V. One child moved to the area at the
age of five with partially displaced hip and was excluded
and one patient refused to participate in the hip study.
In Southern Sweden there were 358 children with CP
with the same inclusion criteria, corresponding to a pre-
valence of 2.70 per 1000 live births. Of these children,
136 (38%) were classified as GMFCS level III - V. Thus,
119 Norwegian and 136 Swedish children fulfilled the
inclusion criteria and their data were further analysed.
The main outcome variable was hip dislocation. Anon-
ymous copies of the most recent, or preoperative, ante-
roposterior (AP) radiographs of the pelvis were
evaluated by one of the authors (GH). The migration
percentage of Reimers (MP) [24] was measured and was
compared with the MP values in the Swedish material.
In hips with a Gothic arch formation of the lateral mar-
gin, the midpoint of the arch was used as a reference
point according to Cooke et al. [5]. Hip dislocation was
defined as MP 100% measured on AP pelvic radiographs
except in one case where complete bilateral dislocation
was diagnosed by computerised tomography (CT) scan-
ning. Three Norwegian children never had radiological
hip examination. In another three children we were not
able to get a copy of the most recent pelvic radiograph,
but the hips were described as normal in the radiolo-
gists’ reports.
The secondary outcome measure, hip surgery, was
classified into soft tissue surgery (adductor- and iliop-
soas muscle lengthening or release), varus derotation
osteotomy of the proximal femur, pelvic osteotomy and
femoral head resection respectively. In the Swedish
population soft tissue operations always included myote-
notomy of adductor longus, gracilis and iliopsoas, while
in the Norwegian population gracilis and iliopsoas mus-
cles were not always included in the procedure. Other
variables used in the study were age, sex and other
modes of spasticity treatment, namely BoNT, intrathecal
baclofen (ITB) and selective dorsal rhizotomy (SDR).
Ethics
In Norway, written informed consent had been obtained
from parents to record detailed clinical data in the Nor-
wegian CP register as required by the Regional Ethics
Committee (REC) for medical research in the healthcare
region of Mid-Norway (reference number: 046-02.2002).
The present study was approved by the same ethics
board (reference number: 2009/984-2). For this study,
parents were informed about the additional collection of
data from the medical records and were given the
opportunity to decline. The analysis of data from the
CP-register in southern Sweden was approved by the
Medical Research Ethics Committee at Lund University
(LU-443-99). This study was carried out in compliance
with Helsinki Declaration.
Statistical analyses
Chi squared statistics was used to assess differences in
proportions between the two study areas, while the dif-
ference in mean age at first operation was analysed by
independent t-test.
Results
In all, 119 Norwegian and 136 Swedish children fulfilled
the inclusion criteria and their data were further ana-
lysed. There were no significant differences between the
Norwegian and Swedish study populations in terms of
CP prevalence, GMFCS levels and gender (Table 1). The
proportion of children classified as dyskinetic CP was,
however, higher in Sweden compared with Norway
where the proportion with bilateral spastic subtype was
higher (Table 1).
Hip dislocation (MP 100%) occurred in 18 children
(15.1%; CI: 9.8 - 22.6) of the Norwegian population; in
nine of them the hips were bilaterally dislocated. Of the
27 dislocated hips, 12 were right and 15 were left sided.
In contrast, in Sweden only one child (0.7%; CI: 0.13 -
4.0), considered to be inoperable, had a dislocated hip
(p < 0.001 versus the Norwegian population).
The number of children operated and the type of hip
surgery are presented in Table 2. The number of chil-
dren operated was 53 (44%; CI: 35.6 - 53.1) in Norway
and 43 (32%; CI: 24.4 - 39.8) in Sweden (p = 0.03). In
Table 1 Distribution of CP-subtype according to SCPE,
GMFCS level and sex in the two study populations
Norway Sweden
n (%) n (%)
119 (100%) 136 (100%) p-
value
CP
-subtype
0.002
Unclassified 4 (3.4) 11 (8.1)
Unilateral 2 (1.7) 2 (1.5)
Bilateral 86 (72.3) 65 (47.8)
Dyskinetic 24 (20.2) 48 (35.3)
Ataxic 3 (2.5) 10 7.4
GMFCS 0.74
Level III 28 (23.5) 36 (26.5)
Level IV 54 (45.4) 55 (40.4)
Level V 37 (31.1) 45 (33.1)
Sex 0.42
Boys 73 (61.3) 74 (54.4)
Girls 46 (38.7) 62 (45.6)
GMFCS, Gross Motor Function Classification System.
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the Norwegian population a higher proportion of chil-
dren underwent merely soft tissue release (Table 2).
Seven of the children with complete hip dislocation did
not undergo hip surgery, three of them died and four
were considered to be inoperable. Nine children under-
went hip surgery once (five had adductor myotenotomy
including psoas in three cases, one had pelvic osteotomy
and three patients had femoral head resection). Two
children were operated on twice (adductor tenotomy
followed by pelvic osteotomy in one case and by femoral
head resection in the other).
The total number and the type of hip operations per-
formed in the two regions are presented in table 3. The
number of hip operations carried out was 65 in the
Norwegian counties and 63 in Southern Sweden.
Children in the surveillance area were operated at an
earlier age compared with areas providing regular care
in Norway (Figure 1). Mean age at first operation was
5.7 years (SD: 2.3) in Sweden and 7.6 years (SD: 2.9) in
Norway (p = 0.001).
Spasticity reducing treatment with BoNT and ITB was
more common in the Norwegian study population than
in the Swedish population, whereas SDR was more com-
mon in Southern Sweden (Table 4).
The mean number of plain anteroposterior x-rays of
the pelvis in Sweden was 9 per patient. In Norway, we
are only able to account for the mean number of x-rays
in two counties. In these two counties, covering 28 of
the children, the mean number of plain pelvic x-rays per
patient was five. However, four pelvic CT scans had
been taken in three of these 28 children. In contrast, no
pelvic CT scans had been performed in any of the
Swedish children.
Discussion
We found, consistent with our main hypothesis, that the
prevalence of hip dislocation was higher in the Norwe-
gian counties providing regular care compared with
Southern Sweden providing hip surveillance services. In
contrast to our second hypothesis, we found that the
surveillance programme did not lead to an increase in
the total number of hip operations. However, children
in the surveillance programme were operated at an ear-
lier age than children offered regular care.
The difference in prevalence of hip dislocation and
operations between the two regions is unlikely to be due
to chance as suggested by the low p-values. A strength
of the present study is the comparison with contempor-
ary rather than historical data, as has been the case in
other studies [6,13]. Thus, our results indicate that a
general improvement in treatment of spasticity and
increased awareness of hip dislocation are unlikely to
explain the effect of the surveillance programme.
Another strength is that all pelvic radiographs in this
study were evaluated by one investigator, since a marked
interrater variation in measurements of the MP has been
reported [25,26]. Moreover, the primary clinical data on
CP diagnosis, subtype, GMFCS and associated impair-
ments were collected prospectively. However, in the
areas providing regular care, data on hip status and sur-
gery had to be collected retrospectively while this was
done prospectively in the surveillance programme.
Table 2 Hip surgery (number of patients)
Norway Sweden
n (%) n (%) p-value
Hip surgery
Soft tissue surgery 28 (23.5) 16 (11.8) 0.013
Femur osteotomy 11 (9.2) 21 (15.4) 0.137
Pelvic osteotomy 10 (8.4) 6 (4.4) 0.191
Femoral head resection 4 (3.4) 0 (0.0) 0.046
Total operated 53 (44.5) 43 (31.6) 0.034
Not operated 66 (55.5) 93 (68.4)
Total 119 (100.0) 136 (100.0)
Table 3 Hip surgery (number of operations)
Norway Sweden
n (%) Operation/patient n (%) Operation/patient p-value
Soft tissue surgery 36 (55.4) 1.3 28 (44.4) 1.8 0.130
Femur osteotomy 13 (20.0) 1.2 29 (46.0) 1.4 0.002
Pelvic osteotomy 12 (15.6) 1.2 6 (9.5) 1.0 0.147
Femoral head resection 4 (6.2) 1.0 0 (0.0) 0.119
Total operations 65 (100.0) 63 (100.0)
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Furthermore, in the surveillance area, more children
(84%) had a recent (in the last two years) pelvic x-ray
than children in the regular care area (73%); a reason-
able effect of the programme (data not shown). Thus, it
is theoretically possible that a case of hip dislocation or
an operation might have been missed among patients
offered regular care. This potential misclassification
would, however, lead to an underestimation of hip dislo-
cations and operations in the regular care areas. A
potential limitation could be that the reviewer of the
radiographs was not blinded to area. However, hip dislo-
cations in the regular care area were originally diag-
nosed as completely dislocated by local clinicians, and
no additional hips were deemed dislocated by the
reviewer of the present study. Regarding the Swedish
population, the radiographs were evaluated prospec-
tively, and before the present study was planned. Since
we used a migration percentage of 100 as a cut-off for
hip dislocation, it is most unlikely that a complete dislo-
cation had been overlooked.
Another potential limitation is the lack of complete
data on 27% of children with CP in the seven Norwe-
gian counties compared with nearly 100% coverage in
Southern Sweden. The primary reason for the missing
data in Norway is actually work overload on local doc-
tors who were not able to complete the CP-registration
forms. Only one family actively refused to participate in
the CP-register, and one further family did not want to
participate in the present study. If a more severely
affected study population had been selected in Norway,
this might have contributed to a higher proportion of
hip dislocations. However, we have provided evidence
that cases included in the Norwegian CP register are
likely to be representative of the total CP population in
a previous study [27]. Moreover, the distribution of chil-
dren within GMFCS levels III - V among all children
with CP was nearly identical in the two areas.
In contrast to the similar distribution of GMFCS levels
in the two study populations, a higher proportion of
children were classified as dyskinetic in Sweden com-
pared with Norway, whereas more children were classi-
fied as bilateral spastic CP in the Norwegian counties.
Figure 1 Age at first hip operation. Number of children (Y-axis) and age (X-axis) at first hip operation in the Norwegian providing regular care
(black bars) and the Swedish population offering a surveillance programme (white bars). Age was grouped in seven categories.
Table 4 Spasticity treatment (number and percent of
children treated)
Norway Sweden
N (%) N (%) p-value
Botulinum
neurotoxin
78 (65.0) 66 (48.5) 0.008
Adductors 55 (45.8) 35 (25.7) 0.001
Iliopsoas 13 (10.8) 0 (0.0) < 0.001
Baclofen
pumpe
29 (24.2) 7 (5.2) < 0.001
Selective
dorsal
rhizotomy
1 (0.8) 6 (4.4) 0.08
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Previous investigators showed a considerable variation in
prevalence of the dyskinetic subtype among European
countries and attributed that to differences in the classi-
fication of CP [20,28]. However, dyskinetic CP also have
increased risk of hip displacement [5,10], and several
studies have shown that GMFCS levels are more corre-
lated to hip displacement than the topographic CP sub-
types [10,11,29]. Thus, taken together, misclassification
or selection bias are unlikely to explain our results.
A potential confounder in this study is that the use of
botulinum neurotoxin and baclofen was more common
in Norway, since it could be expected to reduce the
incidence of hip dislocation [30,31]. However, if this was
the case, it would have reduced the differences between
the groups. On the other hand, one could speculate if
this treatment had masked hip displacement by reducing
spasticity and alleviating pain [32-38].
We are not aware of other studies using the same
approach to study the effectiveness of a hip surveillance
programme to prevent hip dislocations. Our results are,
however, consistent with the studies showing a reduc-
tion in hip dislocation in the total CP population from
8% to nearly 0% in Southern Sweden and elimination of
the need for salvage operations in Australia after com-
mencement of their screening programmes [6,13].
Our results suggest that systematic clinical and radi-
ological follow-up from an early age, as provided by the
hip surveillance programme, lead to early detection of
hip displacement signified by surgical intervention at a
younger age. Nonetheless, the number of children oper-
ated on and the total number of operations was not
higher in the surveillance compared with the regular
care areas. This may be somewhat in contrast to the
increase in preventive surgery which was reported in
Australia after introduction of a similar screening pro-
gramme [13].
In the regular care area 23.5% of the children were
treated with solely soft tissue release which might have
been insufficient to prevent dislocation in some cases
[39-41]. In the surveillance area a higher proportion
underwent femur osteotomy compared with the regular
care areas, and also compared with the Australian sur-
veillance programme. The latter difference is probably
due to a longer observation time in Sweden [6,13]. In
Southern Sweden a standardised protocol is used for hip
surgery as outlined in the CP follow-up programme
(CPUP) with early soft tissue surgery followed by femur
osteotomy in progressive cases [1], and this most prob-
ably explains the variation in types of hip operations in
the two study populations.
The difference in prevalence of hip dislocation
between the two study populations could theoretically
be due to an extraordinary high prevalence in the regu-
lar care areas, or an extremely low prevalence in the
surveillance area, or both. However, the prevalence of
hip dislocation among children with GMFCS III - V in
the regular care area corresponds to an estimated preva-
lence of 5.1% in the total CP-population in this area.
This is lower than the 8% reported in Sweden before
the surveillance programme was introduced and the
14% reported by Scrutton [9] from South East Thames.
Thus, it is unlikely that the prevalence of hip dislocation
is extraordinary high in the seven Norwegian counties
compared to other areas without a surveillance pro-
gramme. In contrast, the prevalence of 0.7% among chil-
dren with GMFCS III - V in the surveillance area in this
study is extremely low, and may not be obtained by
other centres adopting the programme. Nonetheless,
even a seven-fold higher prevalence (4.7% CI: 2.1 - 9.7)
would be considerably lower than in the area providing
regular care (15.1%; CI: 9.8 - 22.6). Thus, it is likely that
the implementation of the surveillance programme in
other populations will result in significant reduction in
the proportion of children with hip dislocation.
Our results suggested that plain pelvic x-rays were
taken more frequently in the surveillance area compared
with the area providing regular care. Although we only
had data from two counties in the regular care area, this
might be a reasonable finding which could be consid-
ered a potential “downside” of the surveillance pro-
gramme. On the other hand, our limited information
suggested that the higher number of x-rays per child in
the surveillance area partly was outweighed by an appar-
ent need for a pelvic CT scan in a few patients in the
regular care area.
Conclusions
Our results suggest that systematic follow up, including
regular radiographic examinations of the pelvis from an
early age, followed by early surgery is essential in pre-
venting hip dislocation among children with severe CP.
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